ReviewInflammation and type 2 diabetesInflammation et diabète de type 2
Introduction
Heart disease, the metabolic syndrome and type 2 diabetes (T2D) all have in common the increased concentration of circulatory cytokines as a result of inflammation [1], [2]. Inflammatory cytokines are produced by different cell types and secreted into the circulation, where they regulate different tissues through their local, central and peripheral actions [3].
Low-grade systemic inflammation is characterized by a two- to threefold increase in systemic plasma concentrations of cytokines such as tumour necrosis factor (TNF)-α, interleukin (IL)-6 and C-reactive protein (CRP) [4]. Cytokines are small proteins (25 kDa) that are released in response to an activating stimulus and induce responses through binding to specific receptors [5]. The cytokines produced by adipose tissue have a key role in promoting atherosclerosis and, therefore, cardiovascular disease (CVD) [6]. The term ‘adipokines’ includes a group of polypeptide hormones that are expressed predominantly, but not exclusively, by adipose tissue [6]. Adiponectin is the only cytokine discussed in the present report that is produced mainly by adipose tissue [4]. In contrast, although TNF-α is produced by adipose tissue, it is also secreted by macrophages and other cells. This cytokine plays a major role in the inflammatory process and, at elevated concentrations, may promote the synthesis of interleukins such as IL-8, the function of which is to induce monocyte adherence, thereby contributing to the atherosclerotic process [7]. TNF-α is also an inflammatory cytokine that has been implicated in metabolic disorders, including obesity and insulin resistance (IR) [8]. CRP is a cytokine that is mainly produced by the liver. Elevated concentrations of CRP have been associated with coronary heart disease (CHD), obesity, diabetes, smoking and a sedentary lifestyle [9]. In contrast, high concentrations of adiponectin are related to greater insulin sensitivity and a lower risk of CVD [4].
Section snippets
Obesity, inflammation and diabetes
Inflammation appears to be a common link between atherosclerosis, obesity and IR [10]. The increase in adipose tissue mass observed in obesity can lead to chronic activation of the innate immune system that, in turn, can lead to IR and T2D over time. Although implicated in the pathogenesis of chronic disease, the innate immune system serves as the critical first line of defense against invading organisms. Innate immune cells recognize molecular prototypes present on pathogens through
C-reactive protein
There are several metabolic consequences specific to T2D due to chronic elevation of proinflammatory cytokines. Elevated concentrations of CRP have been associated with CVD, obesity, diabetes, inflammation, smoking and a sedentary lifestyle. CRP is produced in the liver upon stimulation by IL-6 and TNF-α [27], but it can also be released by mature adipocytes under inflammatory stimulation by LPS, TNF-α and resistin [28]. CRP increases the production of intracellular adhesion molecule-1 (ICAM-1)
Tumor necrosis factor (TNF)-α
TNF-α belongs to the TNF family, which is produced by macrophages, natural killer cells and T cells. In adipose tissue, infiltrated macrophages are the main source of TNF-α [40]. The cytokine is produced 7.5 times more by adipose tissue in obese subjects than in their lean counterparts [8]. TNF-α promotes inflammation and endothelial activation, increasing vascular permeability [5]. The acute local release of TNF-α induces a local inflammatory response to contain infections and, thus, can be
Adiponectin
Adiponectin is an adipose-specific plasma protein with anti-inflammatory [49] and insulin-sensitizing effects [50] induced by activity of the nuclear receptor PPARγ [51]. A decrease in adipose tissue has been associated with increases in adiponectin [52]. Adiponectin is unique in that, unlike other adipokines, its circulating concentrations are reduced in obesity [53]. Data from epidemiological studies indicate that circulating adiponectin is reduced in patients with CVD and diabetes [54]. More
Diabetes and proinflammatory cytokines
As shown in Fig. 1, a genetic predisposition combined with an ‘obesogenic’ environment can lead to obesity and central adiposity. An obesogenic environment is characterized by excess caloric intake and a lack of PA [63]. This may ultimately lead to increases in body weight, resulting in adipose tissue dysfunction, macrophage infiltration [64], and the greater release of cytokines such as IL-6 and TNF-α. Chronically elevated levels of these molecules promote IR in skeletal muscle [64] and
Gut microbiota and diabetes
Over the past few years, intestinal microbiota have been reported to have a causal relationship in the development of metabolic diseases, including diabetes [74]. Recent advances in DNA sequencing have permitted the collection of microbial communities associated with the human gut [75]. Although there are changes in the microbiota between newborns and the elderly, the adult intestinal microflora have been shown to be stable over time [76]. However, metabolic abnormalities have been associated
Diet and proinflammatory cytokines in people at risk of or with type 2 diabetes
There is a fair amount of evidence from epidemiological studies confirming the relationship between diet and variations in inflammatory markers. It is also known that a diet poor in fruits and vegetables is often characterized by low fibre content, and there are also epidemiological data from single-nutrient approaches on how a low intake of fibre is associated with more inflammatory markers and higher T2D risk. The British Regional Heart Study was a case-control study in which 3428 men (aged
Conclusion
There is now a growing body of knowledge on the modes of action of CRP, TNF-α and adiponectin, and their specific roles in the regulation of inflammation and its implications for the development of diabetes. Population studies have reported important correlations between plasma levels of CRP and TNF-α, and an increased risk of heart disease and diabetes. However, increased concentrations of plasma adiponectin are related to insulin sensitivity and a lower risk of heart disease. While there is a
Disclosure of interest
The authors declare that they have no conflicts of interest concerning this article.
References (93)
- et al.
Modulation of C-reactive protein, tumor necrosis-alpha and adiponectin by diet, exercise and weight loss
J Nutr
(2008) - et al.
TNF-α and adipocyte biology
FEBS Lett
(2008) - et al.
Molecular inflammation: underpinnings of aging and age-related diseases
Ageing Res Rev
(2009) - et al.
Inflammation in atherosclerosis. From pathophysiology to practice
J Am Coll Cardiol
(2009) C-reactive protein and the prediction of cardiovascular events among those at intermediate risk. Moving an inflammatory hypothesis toward consensus
J Am Coll Card
(2007)- et al.
C-reactive protein and cardiovascular disease: a review of risk prediction and interventions
Clin. Chim Acta
(2002) - et al.
Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction
J Biol Chem
(1997) - et al.
Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease
Metabolism
(1998) Nuclear factor kappa B-molecular medicine
Biomed Pharmacothe
(2004)- et al.
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
Biochem Biophys Res Commun
(1999)
Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes
Biochem Biophys Res Commun
Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal
Metab Clin Exp
Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma
J Nutr
Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA)
Am J Clin Nutr
Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction
Am J Clin Nutr
Dietary patterns and markers of systemic inflammation among Iranian women
J Nutr
The effects of diet on inflammation. Emphasis on the metabolic syndrome
J Am Coll Cardiol
Raisins and additional walking have distinct effects on plasma lipids and inflammatory cytokines
Lipids Health Dis
Atherosclerosis -an inflammatory disease
N Engl J Med
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans
Am J Physiol Endocrinol Metab
The anti-inflammatory effect of exercise
J Applied Physiol
Janeway's immunobiology
The role of adiponectin in atherosclerosis and thrombosis
Clin Appl Thromb Hemost
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
Nature
The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase
J Clin Invest
Risk factors for the development of atherosclerosis in childhood and adolescence
Arq Bras Cardiol
Recent advances in the relationship between obesity, inflammation, and insulin resistance
Eur Cytokine Netw
TLR4 links innate immunity and fatty acid-induced insulin resistance
J Clin Invest
Mitochondria and aging in the vascular system
J Mol Med
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Cell
Nutrient sensing and inflammation in metabolic diseases
Nat Rev Immunol
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Brit J Nutr
Adipose tissue mass can be regulated through the vasculature
Proc Natl Acad Sci
Targeting HIF-1 for cancer therapy
Nat Rev Cancer
Translating molecular discoveries into new therapies for atherosclerosis
Nature
Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes
J Endocrinol
Cellular hypoxia and adipose tissue dysfunction in obesity
Proc Nutr Soc
Advanced glycoxidation products and impaired diabetic wound healing
Wound Repair Regen
Oxidative stress and diabetic complications
Circulation Res
Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker
Front Biosci (Elite edition)
Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy
Proc Natl Acad Sci U S A
The evolving role of C-reactive protein in atherothrombosis
Clin Chem
Inflammatory process in type 2 diabetes: the role of cytokines
Ann NY Acad Sci
Direct proinflammatory effect of C-reactive protein on human endothelial cells
Circulation
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs
Circulation
C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women
Int J Obesity
Cited by (353)
Association of co-exposure to polycyclic aromatic hydrocarbons and phthalates with oxidative stress and inflammation
2024, Science of the Total EnvironmentIsoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases
2024, Journal of EthnopharmacologySleep Characteristics are Associated with Risk of Treated Diabetes Among Postmenopausal Women
2024, American Journal of MedicineMalondialdehyde and TNF-α lowering effects of purified gambier (Uncaria gambir Roxb.) in diabetic rats
2024, Journal of Ayurveda and Integrative Medicine